PortViewPortView
Drugs Made In America Acquisition Corp. Units logo

Drugs Made In America Acquisition Corp. Units (DMAAU) Stock Analysis

NASDAQFinancial ServicesShell Companies

$10.83+0.37%
1-year price historyRange $10.30 – $11.32
52-week range$10.83
$10.30$12.50

What Drugs Made In America Acquisition Corp. Units does

Drugs Made In America Acquisition Corp. operates as a special purpose acquisition company (SPAC). Its primary objective is to achieve a business combination, which may involve a merger, an asset acquisition, a share exchange, or a corporate restructuring, with one or more existing enterprises. The firm was established on May 23, 2024, and maintains its principal office in Fort Lauderdale, Florida.

Key metrics

Market cap
$253.75M
P/E (TTM)
0.00
Beta
0.20
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$10.89
200-day avg
$10.62
52-week high
$12.50
52-week low
$10.30
CEO
Roger Bendelac

ETFs linked to DMAAU

Broad-market and Financial Services sector ETFs an investor holding Drugs Made In America Acquisition Corp. Units is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DMAAU fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze DMAAU in PortView →

Frequently asked questions

What is the ticker symbol for Drugs Made In America Acquisition Corp. Units?
Drugs Made In America Acquisition Corp. Units trades under the ticker DMAAU on NASDAQ.
Which exchange is DMAAU listed on?
DMAAU is listed on NASDAQ.
What sector does Drugs Made In America Acquisition Corp. Units operate in?
Drugs Made In America Acquisition Corp. Units is classified in the Financial Services sector (Shell Companies industry).
How can PortView help analyze DMAAU in a portfolio?
PortView shows DMAAU's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.